Home » Stocks » Stock Pick: Divi's Laboratories

Stock Pick: Divi's Laboratories

Divi's Laboratories' portfolio management has reaped profits for its investors over the years
By OLM Desk | November 04, 2016

Divi’s Laboratories is a niche player in the pharma space and the company’s product portfolio comprises two broad segments—generic active pharmaceutical ingredients (APIs) and custom synthesis of APIs. Also, it has presence in nutraceuticals and synthesis of speciality ingredients for its clients.

Why: The company is expected to be a major beneficiary of increased outsourcing opportunities driven by its expertise in complex chemistry, cost efficient processes and relationship with global pharma majors.

What: Currency volatility could impact earnings



Download the Outlook Money App and read all the magazine stories on your phone!
Play Store and App Store

On Stands Now